Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Total Stockholders' Equity	Noncontrolling Interest	Convertible Preferred Stock Seed-1, Seed-2, Series A-1, Series A-2, Series B, Series C, Series D, Series E	Convertible Preferred Stock Seed-1, Seed-2, Series A-1, Series A-2, Series B, Series C, Series D, Series E Initial Public Offering	Class A - Common Stock	Class B - Common Stock
Temporary equity, Balance at Dec. 31, 2020								$ 160,713
Temporary equity, Balance, Shares at Dec. 31, 2020								27,758,941
Balance at Dec. 31, 2020	$ (111,249)		$ 503	$ 210	$ (111,962)	$ (111,249)
Balance, Shares at Dec. 31, 2020		7,755,782
Conversion of convertible preferred stock in connection with the initial public offering	160,713		160,713			160,713			$ (160,713)
Conversion of convertible preferred stock in connection with the initial public offering, Shares									(27,758,941)	27,351,633	407,308
Exercise of common stock options	$ 2,291		2,291			2,291
Exercise of common stock options, Shares	1,101,539	910,015								178,402
Conversion of common stock in connection with the initial public offering, Shares		(8,665,797)								6,396,951	2,268,846
Exercise of warrants	$ 40		40			40
Exercise of warrants, Shares										24,242
Issuance of common stock in connection with the initial public offering, net of underwriters' discount	325,263		325,263			325,263
Issuance of common stock in connection with the initial public offering, net of underwriter's discount										7,906,250
Cost of initial public offering	(3,678)		(3,678)			(3,678)
Share issued in business combinations	102,888		102,888			102,888
Share issued in business combinations, Shares										2,100,660
Noncontrolling interest acquired in business combination	1,036						$ 1,036
Donated common stock	2,226		2,226			2,226
Donated common stock, Shares										40,266
Stock based compensation	7,395		7,395			7,395
Comprehensive loss:
Foreign currency translation	(61)			(61)		(61)
Net (loss) income	(61,381)				(61,379)	(61,379)	(2)
Comprehensive (loss) income	(61,442)			(61)	(61,379)	(61,440)	(2)
Balance at Dec. 31, 2021	425,483		597,641	149	(173,341)	424,449	1,034
Balance, Shares at Dec. 31, 2021										43,998,404	2,676,154
Exercise of common stock options	$ 3,715		3,715			3,715
Exercise of common stock options, Shares	682,958									684,916
Vesting of restricted stock units,shares										72,968
Other common stock issued	$ 281		281			281
Other common stock issued, Shares										5,577
Donated common stock	2,272		2,272			2,272
Donated common stock, Shares										60,399
Stock based compensation	19,172		19,172			19,172
Comprehensive loss:
Foreign currency translation	(81)			(121)		(121)	40
Net (loss) income	(79,043)				(79,059)	(79,059)	16
Comprehensive (loss) income	(79,124)			(121)	(79,059)	(79,180)	56
Balance at Dec. 31, 2022	371,799		623,081	28	(252,400)	370,709	1,090
Balance, Shares at Dec. 31, 2022										44,822,264	2,676,154
Exercise of common stock options	$ 1,909		1,909			1,909
Exercise of common stock options, Shares	264,445									274,680
Vesting of restricted stock units,shares										328,474
Share issued in business combinations	$ 180		180			180
Share issued in business combinations, Shares										3,562
Donated common stock	1,029		1,029			1,029
Donated common stock, Shares										60,399
Stock based compensation	22,118		22,118			22,118
Comprehensive loss:
Foreign currency translation	849			827		827	22
Net (loss) income	(67,465)				(67,472)	(67,472)	7
Comprehensive (loss) income	(66,616)					(66,645)	29
Balance at Dec. 31, 2023	$ 330,419		$ 648,317	$ 855	$ (319,872)	$ 329,300	$ 1,119
Balance, Shares at Dec. 31, 2023										45,489,379	2,676,154